This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Haplnscience Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yong Wei Piao: Innovator in Pulmonary Disease Treatment
Introduction
Yong Wei Piao is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary diseases. His innovative work focuses on utilizing recombinant proteins to address serious health issues.
Latest Patents
Yong Wei Piao holds a patent for a composition aimed at preventing or treating pulmonary diseases. The patent, titled "Composition for preventing or treating pulmonary diseases comprising hyaluronan and proteoglycan link protein 1," introduces a recombinant hyaluronan and proteoglycan link protein 1 (HAPLN1). This composition includes at least one component selected from HAPLN1 protein, a gene coding for the HAPLN1 protein, and an effective agent that promotes the expression or activates the functions of HAPLN1. The recombinant HAPLN1 has shown superior effects in improving alveolar damage caused by aging or elastin reduction, making it a promising candidate for treating chronic bronchitis, asthma, emphysema, and chronic obstructive pulmonary disease.
Career Highlights
Yong Wei Piao is associated with Haplnscience Inc., where he continues to develop innovative solutions for pulmonary health. His work has garnered attention for its potential to significantly improve patient outcomes in respiratory diseases.
Collaborations
He collaborates with talented individuals such as Dae Kyong Kim and Ji Min Jang, who contribute to the research and development efforts at Haplnscience Inc.
Conclusion
Yong Wei Piao's contributions to the field of pulmonary disease treatment through his innovative patent highlight his role as a leading inventor in medical science. His work promises to enhance the quality of life for individuals suffering from respiratory conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile